BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 26560046)

  • 21. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional interaction between human papillomavirus type 16 E6 and E7 oncoproteins and cigarette smoke components in lung epithelial cells.
    Muñoz JP; González C; Parra B; Corvalán AH; Tornesello ML; Eizuru Y; Aguayo F
    PLoS One; 2012; 7(5):e38178. PubMed ID: 22662279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
    Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
    BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer.
    D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY
    PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-4454 up-regulated by HPV16 E6/E7 promotes invasion and migration by targeting ABHD2/NUDT21 in cervical cancer.
    Wang H; Hu H; Luo Z; Liu S; Wu W; Zhu M; Wang J; Liu Y; Lu Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32816024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells.
    Dai L; Cao Y; Jiang W; Zabaleta J; Liu Z; Qiao J; Qin Z
    Oncotarget; 2017 May; 8(22):35792-35803. PubMed ID: 28415759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma.
    Wu MZ; Li WN; Cha N; Tian LX; Zhang YI; Wu X; Guo KJ; Wu GP
    Cell Transplant; 2018 Sep; 27(9):1401-1406. PubMed ID: 30056761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virological characteristics of cervical cancers carrying pure episomal form of HPV16 genome.
    Cheung JL; Cheung TH; Yu MY; Chan PK
    Gynecol Oncol; 2013 Nov; 131(2):374-9. PubMed ID: 24012799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.
    Smith SP; Scarpini CG; Groves IJ; Odle RI; Coleman N
    Sci Rep; 2016 Jul; 6():29832. PubMed ID: 27457222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.
    Hasan UA; Bates E; Takeshita F; Biliato A; Accardi R; Bouvard V; Mansour M; Vincent I; Gissmann L; Iftner T; Sideri M; Stubenrauch F; Tommasino M
    J Immunol; 2007 Mar; 178(5):3186-97. PubMed ID: 17312167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV16 E6 promotes cervical cancer cell migration and invasion by downregulation of NHERF1.
    Wang Q; Song R; Zhao C; Liu H; Yang Y; Gu S; Feng D; He J
    Int J Cancer; 2019 Apr; 144(7):1619-1632. PubMed ID: 30230542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanog, in Cooperation with AP1, Increases the Expression of E6/E7 Oncogenes from HPV Types 16/18.
    Díaz-Tejeda Y; Guido-Jiménez MC; López-Carbajal H; Amador-Molina A; Méndez-Martínez R; Gariglio-Vidal P; Lizano M; García-Carrancá A
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells.
    Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y
    Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.
    Scarpini CG; Groves IJ; Pett MR; Ward D; Coleman N
    J Pathol; 2014 Jul; 233(3):281-93. PubMed ID: 24752734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the Role of E6 and E7 Oncoproteins in Cervical Oncogenesis through MBD2/3-NuRD Complex Chromatin Remodeling.
    Fudulu A; Diaconu CC; Iancu IV; Plesa A; Albulescu A; Bostan M; Socolov DG; Stoian IL; Balan R; Anton G; Botezatu A
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
    Ajiro M; Zheng ZM
    mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression.
    Mazumder Indra D; Singh RK; Mitra S; Dutta S; Chakraborty C; Basu PS; Mondal RK; Roychoudhury S; Panda CK
    Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
    Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.